DiseaseID 4458
急性早幼粒细胞白血病
disease
NCI2016_NCI-GLOSS_1602D:An aggressive (fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of c
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Herb: 2Symptom: 7Target: 27Links: 37
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 4458
- Core Entity Id
- 60808
- Source Entity Count
- 1
- Preferred Name
- Acute Promyelocytic Leukemia
- Name Cn
- 急性早幼粒细胞白血病
- Name Pinyin
- Ji Xing Zao You Li Xi Bao Bai Xue Bing
- Name En
- Acute Promyelocytic Leukemia
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Neoplastic Process
- Disgenet Type
- disease
- Mesh Class
- Neoplasms
- Do Class
- disease of anatomical entity; disease of cellular proliferation
- Hpo Class
- Abnormality of the immune system; Abnormality of blood and blood-forming tissues; Neoplasm
- Mesh Class Name
- Neoplasms
- Hpo Class Name
- Abnormality of the immune system; Neoplasm; Abnormality of blood and blood-forming tissues
- Do Class Name
- disease of anatomical entity; disease of cellular proliferation
- Disease Definition
- NCI2016_NCI-GLOSS_1602D:An aggressive (fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of chromosomes 15 and 17.|NCI2016_02D:An acute myeloid leukemia (AML) in which abnormal promyelocytes predominate. It is characterized by the t(15;17)(q22;q12) translocation. There are two variants: the typical and microgranular variant. This AML is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. (WHO, 2001)|MSH2017_2016_08_12:An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.|HPO2016_07_04:A type of acute myeloid leukemia in which abnormal promyelocytes predominate. [HPO:probinson]
- Version
- v1,v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Acute Promyelocytic Leukemia
Role
preferred
Name
Acute Promyelocytic Leukaemia
Role
alias
Name
Leukemia, Acute Promyelocytic
Role
alias
Name
Leukemia, Promyelocytic, Acute
Role
alias
Cross References
Trusted external identifiers retained for this final record.
Hpo
HP:0004836
Herb
HBDIS001721
Me Sh
D015473
Omim
612376
Umls
C0023487
Icd10
C92.4C92.40
Sym Map
SMDE00100
Do Class
DOID:14566DOID:7
Dis Ge Net
C0023487
Umls Sty
T191
Hpo Class
HP:0001871HP:0002664HP:0002715
Me Sh Class
C04
Etcm Disease
Acute Promyelocytic Leukemia
Tcmbank Disease
15208
Itcmdb Generated
ITX-DISEASE-2C84E00F6057
Attributes
Merged source attributes and domain-specific metadata.
Version
v1,v2
Suppress
0
Page Title
Disease Acute Promyelocytic Leukemia Details page
Do Class Name
disease of anatomical entity; disease of cellular proliferation
Disease Type
disease
Hpo Class Name
Abnormality of the immune system; Neoplasm; Abnormality of blood and blood-forming tissues
Do Disease Class
disease of anatomical entity; disease of cellular proliferation
Hpo Disease Class
Abnormality of the immune system; Abnormality of blood and blood-forming tissues; Neoplasm
Umls Disease Type
Neoplastic Process
Basic Information
Disease Name
Acute Promyelocytic Leukemia
Global Category
Cancer diseases;Genetic diseases;Rare diseases
Anatomical Category
Blood diseases
Disease Definition
NCI2016_NCI-GLOSS_1602D:An aggressive (fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of chromosomes 15 and 17.|NCI2016_02D:An acute myeloid leukemia (AML) in which abnormal promyelocytes predominate. It is characterized by the t(15;17)(q22;q12) translocation. There are two variants: the typical and microgranular variant. This AML is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. (WHO, 2001)|MSH2017_2016_08_12:An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.|HPO2016_07_04:A type of acute myeloid leukemia in which abnormal promyelocytes predominate. [HPO:probinson]
Me Sh Disease Class
Neoplasms
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Neoplasms
Umls Semantic Type Name
Neoplastic Process